Does bortezomib influence pre‐transplant desensitization therapy or benefit post‐heart transplant outcomes for highly sensitized patients?
Saved in:
| Title: | Does bortezomib influence pre‐transplant desensitization therapy or benefit post‐heart transplant outcomes for highly sensitized patients? |
|---|---|
| Authors: | Dhillon, Manvir1 (AUTHOR) Manvir.Dhillon@cshs.org, Kobashigawa, Jon A.1 (AUTHOR), Kittleson, Michelle1 (AUTHOR), Jain, Rashmi1 (AUTHOR), Patel, Nikhil1 (AUTHOR), Singer‐Englar, Tahli1 (AUTHOR), Zhang, Xiaohai1 (AUTHOR), Hakimi, Matthew1 (AUTHOR), Aintablian, Tamar1 (AUTHOR), Vescio, Robert1 (AUTHOR), Dilibero, Deanna1 (AUTHOR), Kransdorf, Evan1 (AUTHOR), Czer, Lawrence1 (AUTHOR), Nikolova, Andriana P.1 (AUTHOR), Patel, Jignesh K.1 (AUTHOR) |
| Source: | Clinical Transplantation. Jan2024, Vol. 38 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
